Hamad Medical Corporation

Quick facts

Marketed products

• Bivalirudin Injection
• Buccal midazolam · Neurology, Anesthesia
  Buccal midazolam is a benzodiazepine that enhances inhibitory GABAergic neurotransmission in the central nervous system to produce sedation and anxiolysis.
• Ceftolozane-tazobactam IV · Infectious Disease
  Ceftolozane-tazobactam is a beta-lactam antibiotic combined with a beta-lactamase inhibitor that kills bacteria by inhibiting cell wall synthesis while protecting against enzymatic degradation.
• Dexamethasone Oral · Immunology, Rheumatology, Endocrinology, Oncology (supportive care)
  Dexamethasone is a synthetic glucocorticoid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors in the cytoplasm.
• Diclofenac and Paracetamol
• Fairhaven Pro for men
• Human albumin · Critical Care; Hematology; Trauma
  Human albumin acts as a plasma volume expander and carrier protein that restores intravascular oncotic pressure and transports endogenous and exogenous substances throughout the body.
• Intramuscular midazolam · Psychiatry/Neurology
  Midazolam is a benzodiazepine that enhances the inhibitory effects of GABA at GABA-A receptors in the central nervous system, producing sedation, anxiolysis, and muscle relaxation.
• Intranasal Midazolam · Neurology; Psychiatry
  Midazolam is a benzodiazepine that enhances the inhibitory effects of GABA at GABA-A receptors in the central nervous system, producing sedation and anxiolysis.
• Levobupivacaine and Fentanyl · Anesthesia and Pain Management
  Levobupivacaine blocks sodium channels to provide local anesthesia, while fentanyl activates opioid receptors to provide analgesia.
• Nebulized Lidocaine
• (TauroLock Hep500) · Infectious Disease / Vascular Access
  TauroLock Hep500 is a catheter lock solution that prevents bacterial biofilm formation and thrombosis in central venous catheters through a combination of taurolidine and heparin.
• TauroLock U 25000 · Infectious Disease / Critical Care
  TauroLock U 25000 is an antimicrobial lock solution that prevents biofilm formation and catheter-related bloodstream infections by combining taurolidine with heparin and uracil.
• Treatment 1. Metoclopramide
• Treatment 2 Ondansetron · Oncology, Gastroenterology
  Ondansetron blocks serotonin (5-HT3) receptors on chemoreceptor trigger zone and vagal afferent nerves to prevent nausea and vomiting.

Phase 3 pipeline

• Anti TNF + Meth · Immunology
  This combination therapy blocks tumor necrosis factor (TNF) to suppress inflammatory immune responses while methotrexate inhibits dihydrofolate reductase to reduce cell proliferation and immune activation.
• Hi-dose iv MgSO4 · Neurology
  High-dose intravenous magnesium sulfate acts as a neuroprotective agent and anticonvulsant by blocking N-methyl-D-aspartate (NMDA) receptors and stabilizing neuronal membranes.
• Homologous Blood Transfusion · Hematology/Transfusion Medicine
  Homologous blood transfusion replaces lost or deficient blood volume and cellular components to restore oxygen-carrying capacity and hemostatic function.
• Nebulized Fentanyl · Pain Management, Anesthesia
  Nebulized fentanyl is an inhaled opioid agonist that binds to mu opioid receptors in the central nervous system to provide rapid analgesia and sedation.
• Pioglitazone Plus dapaglifliozin · Diabetes
  Pioglitazone is a thiazolidinedione that activates PPAR-γ, increasing insulin sensitivity, while dapagliflozin is an SGLT2 inhibitor that reduces glucose reabsorption in the kidneys.
• Pred + Meth · Immunology / Rheumatology
  A combination of prednisolone (a corticosteroid) and methotrexate (an immunosuppressant/antimetabolite) that suppresses inflammation and immune activity.
• Std-dose iv MgSO4 · Cardiovascular, Neurology
  Magnesium sulfate acts as an anticonvulsant and vasodilator by inhibiting neuronal excitability and promoting blood vessel dilation.

Phase 1 pipeline

• Ondansetron with1:1 ORA - sweet.
• Vancomycin-traditional dosing
• Vancomycin- Trough-only based dosing
• Vitamin D Deficiency

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Hamad Medical Corporation portfolio CI brief
• Hamad Medical Corporation pipeline updates RSS